CSBR vs K · P/E 16, rev $56.9M vs P/E 23, $29.03B cap
Champions Oncology Inc (CSBR) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
K does not have a complete income-statement cache yet.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the CSBR and K stock pages for the full models.
Not investment advice.